Wednesday, December 01, 2021 6:32:11 PM
I did not comment in the past on what I thought of management as the share price ran to 34.00.
The reason being is I felt that none of that increase had anything to do with their actions.
The price run was simply market rumor 4 suitors, the main one being BMY.
Since they had come out and stated they were presenting an offer. (Though if I remember correctly BMY stated they were looking at a takeover.)
Takeover could be different things...
A buyout
A hostile takeover, which if so, would justify the new shelf, allowing the company to gain over 50% control under all circumstances.
That was oct 22. so just over 5 weeks and right now we are sitting at the same share price we were then.
Had we seen a buyout I would have split the praise between management and the new partner.
I would at this point bet there is no buyout coming from BMY.
I would also spec-o-late that there will not be a B/O any time between now and through the end of 2022.
All that I see on the outside points to GIA which I personally believe is a dangerous play for a new company with a new drug.
The companies that are able to capitalize on new drugs are the ones who already have a sales force in the doctors face and can get in front of those who would be the buyers.
I believe greed is playing its ugly hand with management and their previous comments about shareholder value and getting the drug to as many as possible who need it now was a nice talking point but has been shelved.
I look art this from the point of view as a person who started and ran my own company from nothing and zero funding from any shareholders.
I have a degree in Business Management and Marketing.
So I leave it with the fact that in 1 month we have risen, only to lose 50% value and management says nothing.
If something was happening leaks would sneak out, funds would be buying allowing a stable share price.
Any stock that loses half of its value should be a concern to anyone who has put his/her money on the line.
And YES Shareholders deserve better treatment from management, It is OUR company and we have a right to know and management has an obligation to inform shareholders.
I stick with my 15.00 share price by Christmas, probably lower.
And to those of you who post every time you pick up more cheap shares, well today they are much cheaper than what you paid last week.
And you should keep it to yourself, there are those waiting in the background, always waiting to prey on those with a future large windfall.
And as much as I hate to say it so far BR is the only winner here. I wish I was will to sell at 30.00, If I had 5 minutes later there would have been a 80.00 BO
Recent AUPH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:56:55 PM
- Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference • Business Wire • 09/13/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:08:25 PM
- Aurinia Announces Board Restructuring • Business Wire • 09/12/2024 08:05:00 PM
- Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial • Business Wire • 09/05/2024 10:00:00 AM
- Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 08/28/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:06:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 10:07:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 10:03:38 AM
- Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results • Business Wire • 08/01/2024 10:00:00 AM
- Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024 • Business Wire • 07/19/2024 10:00:00 AM
- Aurinia to Participate in Upcoming Investor Healthcare Conferences • Business Wire • 07/02/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:25:28 PM
- Aurinia Announces 2024 Annual General Meeting Results • Business Wire • 06/14/2024 04:16:00 PM
- Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024 • Business Wire • 06/05/2024 10:00:00 AM
- Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce • Business Wire • 06/04/2024 09:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/04/2024 09:25:39 PM
- Aurinia Provides Update on Proxy Statement • Business Wire • 06/03/2024 10:30:00 PM
- Aurinia Will Attend 2024 Jefferies Global Healthcare Conference • Business Wire • 05/30/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:16:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:11:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:09:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:07:15 PM
- Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024 • Business Wire • 05/14/2024 10:00:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM